Publications

Publications in international peer-reviewed journals

1. Attema AE, Li Z (forthcoming). Reference-dependent discounting. Journal of Risk and Uncertainty.

2. Lang Z, Attema AE, Lipman SA (2024). The effect of duration and time preference on the gap between adult and child health state valuations in time trade-off. The European Journal of Health Economics, 25, 601-613.

3. Antonini, M., Genie, M. G., Attema, A.E., Attwell, K., Balogh, Z. J., Behmane, D., ... & Paolucci, F. (2024). Public preferences for vaccination campaigns in the COVID-19 endemic phase: Insights from the VaxPref database. Health Policy and Technology, 100849. 

4. Attema AE. Lang Z, Lipman SA (2023). Can independently elicited adult- and child-perspective health state utilities explain priority setting? Value in Health, 26(11). 1645-1654.

5. Attema AE, L'Haridon O, van de Kuilen G (2023). An experimental investigation of social risk preferences for health. Theory and Decision, 95, 379-403.

6. Neumann-Böhme S, Sabat I, Brinkmann C, Attema AE, Stargardt T, Schreyögg J,  Brouwer WBF (2023). Jumping the queue. Willingness to pay for faster access to COVID-19 vaccines in seven European countries. Pharmacoeconomics, 41, 1389-1402.

7. Attema AE, L'Haridon O, van de Kuilen G (2023). Decomposing social risk preferences for health and wealth. Journal of Health Economics, 90, 102757.

8. Lipman SA, Zhang L, Shah KK, Attema AE (2023). Time and lexicographic preferences in the valuation of EQ-5D-Y with time trade-off methodology. The European Journal of Health Economics, 24(2), 293-305.

9. Attema AE, Galizzi MM, Gross M, Hennig-Schmidt H, Karay Y, L’Haridon O, Wiesen D (2023). The formation of physician altruism. Journal of Health Economics, 87, 102716. 

10. Attema AE, Brouwer WBF, Pinto JL (2022). Reference-dependent age weighting of quality-adjusted life years. Health Economics, 31 (12), 2515-2536. 

11. Attema AE, Brouwer WBF, Pinto JL (2022). The role of perceived utility of full health in age weighting. Value in Health, 25 (9), 1559-1565.

12. Attema AE, L'Haridon O, Pinto JL (2022). Editorial: Behavioral and experimental health economics. Frontiers in Health Services, 2: 991135.

13. Lipman SA, Attema AE, Versteegh MM (2022). Correcting for discounting and loss aversion in composite time trade-off. Health Economics, 31 (8), 1633-1648. Corrigendum.

14. Neumann-Böhme S, Sabat I, Attema AE (2022). Altruism and the link to pro-social pandemic behavior. Frontiers in Health Services, 2: 871891.

15. Yang M, Roope L, Buchanan J, Attema AE, Clarke P, Walker AS, Wordsworth S (2022). Eliciting risk preferences that predict risky health behavior: A comparison of two approaches. Health Economics, 31 (5), 836-858.

16.  Stolk-Vos AC, Attema AE, Manzulli M, van de Klundert JJ (2022). Do patients and other stakeholders value health service quality equally? A prospect theory based choice experiment in cataract care. Social Science & Medicine, 294, 114730.

17. Attema AE, Frasch JJ, L'Haridon O (2022). Multivariate risk preferences in the quality-adjusted life year model.  Health Economics, 31 (2), 382-398.

18. Lipman SA, Reckers-Droog VT, Karimi M, Jakubczyk M, Attema AE (2021). Self vs. other, child vs. adult. An experimental comparison of valuation perspectives for valuation of EQ-5D-Y-3L health states. The European Journal of Health Economics, 22, 1507-1518.

19. Neumann-Böhme S, Attema AE, Brouwer WBF, van Exel NJA (2021). Life satisfaction: the role of domain-specific reference points. Health Economics, 30 (11), 2766-2779.

20. Neumann-Böhme S, Lipman SA, Brouwer WBF, Attema AE (2021). Trust me; I know what I am doing. Investigating the effect of choice list elicitation and domain-relevant training on preference reversals in decision making for others. The European Journal of Health Economics, 22, 679-697.

21. Attema AE, L'Haridon O, Raude J, Seror V, The COCONEL Group (2021). Beliefs and risk perceptions about COVID-19: evidence from two successive French representative surveys during lockdown. Frontiers in Psychology, 12: 619145.

22. Lipman SA, Brouwer WBF, Attema AE (2020). What is it going to be, TTO or SG? A direct test of the validity of health state valuation. Health Economics, 29 (11), 1475-1481. 

23. Lipman SA, Brouwer WBF, Attema AE (2020). Living up to expectations: Experimental tests of subjective life expectancy as reference point in time trade-off and standard gamble. Journal of Health Economics, 71, 102318.

24. Attema AE, Bleichrodt H, L'Haridon O, Lipman SA (2020). A comparison of individual and collective decision making for standard gamble and time trade-off. The European Journal of Health Economics, 21 (3), 465-473.

25. Lipman SA, Attema AE (2020). Good things come to those who wait - decreasing impatience for health gains and losses. PLoS ONE 15(3): e0229784 

26. Lipman SA, Attema AE (2019). Rabin's paradox for health outcomes. Health Economics, 28 (8), 1064-1071.

27. Lipman SA, Brouwer WBF, Attema AE (2019). The corrective approach: policy implications of recent developments in QALY measurement based on prospect theory. Value in Health, 22 (7), 816-821.

28. Lipman SA, Brouwer WBF, Attema AE (2019). QALYs Without Bias? Non-Parametric Correction of Time Trade-Off and Standard Gamble Weights Based on Prospect Theory. Health Economics, 28 (7), 843-854.

29. Attema AE, He L, Cook AJC, Del Rio Vilas VJ (2019). Unbiased assessment of disease surveillance utilities: a prospect theory application. PLoS Neglected Tropical Diseases, 13 (5), e0007364. 

30. Attema AE, L'Haridon O, van de Kuilen G (2019). Measuring multivariate risk preferences in the health domain. Journal of Health Economics, 64, 15-24. Media coverage: The Academic Health Economists' Blog, December 31st, 2018

31. Lipman SA, Brouwer WBF, Attema AE (2019). A QALY loss is a QALY loss is a QALY loss: A note on independence of loss aversion from health states. The European Journal of Health Economics, 20 (3), 419-426.

32. Attema AE, Bleichrodt H, l’Haridon O (2018). Ambiguity preferences for health. Health Economics, 27 (11), 1699-1716.

33. Attema AE, Bleichrodt H, l’Haridon O, Perreti-Wattel P, Seror, V (2018). Discounting Health and Money: New evidence using a more robust method. Journal of Risk and Uncertainty, 56 (2), 117-140.

34. Attema AE, Brouwer WBF, Claxton K (2018). Discounting in economic evaluations. Pharmacoeconomics, 36 (7), 745-758.

35. Attema AE, Brouwer WBF, Pinto JL (2018). Peer effects in health valuation: The relation between rating of contemporaries' health and own health. Health and Quality of Life Outcomes 16: 148.

36. Attema AE, Krol HM, van Exel NJA, Brouwer WBF (2018). New findings from the TTO for income approach to elicit willingness to pay for a QALY. The European Journal of Health Economics, 19 (2), 277-291.

37. Attema AE, Lipman SA (2018). Decreasing impatience for health outcomes and its relation with healthy behavior. Frontiers in Applied Mathematics and Statistics,  4 (16).

38. Rouyard T, Attema AE, Baskerville R, Leal J, Gray A (2018). Risk attitudes of people with ‘manageable’ chronic disease: an analysis under prospect theory. Social Science & Medicine, 214, 144-153.

39. Jonker MF, Attema AE, Versteegh MM, Donkers B, Stolk EA (2017). Are health state valuations from the general public biased? A test of health state reference dependency using self-assessed health and anefficient discrete choice experiment. Health Economics, 26 (12), 1534-1547.

40. Attema AE, Bleichrodt H, Gao Y, Huang Z, Wakker PP (2016). Measuring discounting without measuring utility. American Economic Review, 106 (6), 1476-1494. This paper was on the five-paper shortlist for the Exeter 2017 prize. A report is on pp. 6-7 of the JDM newsletter of October 2017.

41. Attema AE, Brouwer WBF, l'Haridon O, Pinto JL (2016). An elicitation of utility for quality of life under prospect theory. Journal of Health Economics, 48, 121-134. Media coverage: The Academic Health Economists' Blog, May 16th, 2016

42. Krol HM, Attema AE, van Exel NJA, Brouwer WBF (2016). Altruistic preferences in time tradeoff: Considerations of effects on others in health state valuations. Medical Decision Making, 36 (2), 187-198.

43. Tilling C, Krol HM, Attema AE, Tsuchiya A, Brazier J, van Exel NJA, Brouwer WBF (2016). Exploring a new method for deriving the monetary value of a QALY. The European Journal of Health Economics, 17 (7), 801-809.

44. Attema AE (2015). Incorporating sign-dependence in health-related social welfare functions. Expert Review of Pharmacoeconomics & Outcomes Research, 15 (2), 223-228.

45. Attema AE, Brouwer WBF, l'Haridon O, Pinto JL (2015). Estimating sign-dependent societal preferences for quality of life. Journal of Health Economics, 43, 229-243.

46. Attema AE, Brouwer WBF (2014). Deriving time discounting correction factors for TTO tariffs. Health Economics, 23 (4), 410-425.

47. Attema AE, Brouwer WBF, van Exel NJA (2014). Your right arm for a publication in AER? Economic Inquiry, 52 (1), 495-502. Media coverage: Economisch Statistische Berichten, September 25th, 2014, Harvard Business Review, December 23rd, 2013, Pacific Standard, April 25th, 2013

48. Attema AE, Brouwer WBF (2013). In search of a preferred preference elicitation method: A test of the internal consistency of choice and matching tasks.Journal of Economic Psychology, 39, 126-140.

49. Attema AE, Brouwer WBF, l'Haridon O (2013). Prospect theory in the health domain: a quantitative assessment. Journal of Health Economics, 32(6), 1057-1065.* Comment. *This paper was awarded the NVTAG MTA price 2012/2013 for innovative methodological research in medical technology assessment.

50. Attema AE, Edelaar-Peeters Y, Versteegh MM, Stolk EA (2013). Time trade-off: one methodology, different methods. The European Journal of Health Economics, 14(Suppl 1), S53-S64.

51. Attema AE, Versteegh MM (2013). Would you rather be ill now, or later? Health Economics, 22(12), 1496-1506.

52. Attema AE, Versteegh MM, Oppe M, Brouwer WBF, Stolk EA (2013). Lead time TTO: Leading to better health state valuations? Health Economics, 22(4), 376-392.

53. Versteegh MM, Attema AE, Oppe M, Devlin NJ, Stolk EA (2013). Time to tweak the TTO: results from a comparison of alternative specifications of the TTO. The European Journal of Health Economics, 14(Suppl 1), S43-S51.

54. Attema AE (2012). Developments in time preference and their implications for medical decision making. Journal of the Operational Research Society, 63(10), 1388-1399. Comment.

55. Attema AE, Bleichrodt H, Wakker PP (2012). A direct method for measuring discounting and QALYs more easily and reliably. Medical Decision Making, 32(4), 583-593. Web appendix Dataset

56. Attema AE, Brouwer WBF (2012). The way that you do it? An elaborate test of procedural invariance of TTO, using a choice-based design. The European Journal of Health Economics, 13(4), 491-500.

57. Attema AE, Brouwer WBF (2012). A test of independence of discounting from quality of life. Journal of Health Economics, 31(1), 22-34.

58. Attema AE, Brouwer WBF (2012). Constantly Proving The Opposite? A test of CPTO using a broad time horizon and correcting for discounting. Quality of Life Research, 21(1), 25-34.

59. Abdellaoui M, Attema AE, Bleichrodt H (2010). Intertemporal tradeoffs for gains and losses: an experimental measurement of discounted utility. The Economic Journal, 120(545), 845-866.

60. Attema AE, Bleichrodt H, Rohde KIM, Wakker PP (2010). Time-tradeoff sequences for analyzing discounting and time inconsistency. Management Science, 56(11), 2015-2030. Comment, Dataset

61. Attema AE, Brouwer WBF (2010). On the (not so) constant proportional trade-off in TTO. Quality of Life Research, 19(4), 489-497.

62. Attema AE, Brouwer WBF (2010). The value of correcting values: Influence and importance of correcting TTO scores for time preference. Value in Health, 13(8), 879-884.

63. Attema AE, Lugnér AK, Feenstra TL (2010). Investment in antiviral drugs: A real options approach. Health Economics, 19(10), 1240-1254.

64. Attema AE, Brouwer WBF (2009). The correction of TTO-scores for utility curvature using a risk-free utility elicitation method. Journal of Health Economics, 28(1), 234-243.

65. Attema AE, Brouwer WBF (2008). Can we fix it? Yes we can! But what? A new test of procedural invariance in TTO-measurement. Health Economics, 17(7), 877-885.

Book chapters

1. Pinto Prades, José Luis; Attema, AE; Sánchez Martínez, Fernando Ignacio (2019). Measuring Health Utility in Economics. In the Oxford Encyclopedia of Health Economics. Oxford University Press. doi: http://dx.doi.org/10.1093/acrefore/9780190625979.013.85. 

2. Attema AE, Brouwer WBF (2014). Constant proportional trade-offs and health state evaluations. In: Michalos AC (Ed.), Encyclopedia of Quality of Life  and Well-Being Research. Dordrecht: Springer, pp. 1207-1212.

Publications in national journals

1. Versteegh MM,  Attema AE, Uyl-de Groot CA (2019). Is verlies winst? Stoppen met TNF-alfaremmers. Nederlands Tijdschrift voor Geneeskunde, 163:D3709.

2. Attema AE (2017). De meting van maatschappelijke voorkeuren voor gezondheid(szorg) vanuit een gedragseconomisch perspectief. TPEdigitaal, 11 (2), 36-48. (In Dutch).

3. Attema AE (2017). Economische inzichten in stimulatie van gezond gedrag: de voor- en nadelen van een financiële prikkel. Nederlands Tijdschrift voor Geneeskunde, 161, D1933. (In Dutch).

4. Attema AE (2009). De TTO-methode en correctie voor tijdsvoorkeur. VGE Bulletin, 26(2), 14-17. (In Dutch.)

5. Attema AE (2008). De rol van tijdsvoorkeur bij de waardering van gezondheid. TPEdigitaal, 2(4), 92-105. (In Dutch.)

6. Attema AE (2006). Measuring proneness to arbitrage using only pencil and paper. Medium Econometrische Toepassingen, 14(4), 2-6.

Interviews

1. Economisch Statistische Berichten, Year 101, Vol. 4725, p.32, January 7th, 2016. “Ceteris paribus: Het woord aan…” (In Dutch).